2024. Bimekizumab impact on patient-reported outcomes in patients with moderate to severe hidradenitis suppurativa: Pooled Week 48 results from BE HEARD I&II. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s476. DOI:https://doi.org/10.25251/skin.8.supp.476.